619 related articles for article (PubMed ID: 17986236)
21. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
22. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
Yamamura S; Ohoyama K; Nagase H; Okada M
Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
[TBL] [Abstract][Full Text] [Related]
23. Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons.
Xing GG; Wang R; Yang B; Zhang D
Eur J Neurosci; 2006 Dec; 24(11):2987-92. PubMed ID: 17156360
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat.
Morari M; Sbrenna S; Marti M; O'Connor WT; Bianchi C; Fuxe K; Beani L
Eur J Neurosci; 1998 May; 10(5):1716-22. PubMed ID: 9751143
[TBL] [Abstract][Full Text] [Related]
25. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.
Byrnes EM; Reilly A; Bruno JP
Synapse; 1997 Jul; 26(3):254-68. PubMed ID: 9183815
[TBL] [Abstract][Full Text] [Related]
26. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
27. Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.
Bido S; Marti M; Morari M
J Neurochem; 2011 Sep; 118(6):1043-55. PubMed ID: 21740438
[TBL] [Abstract][Full Text] [Related]
28. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
Lee CR; Abercrombie ED; Tepper JM
Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
[TBL] [Abstract][Full Text] [Related]
29. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
30. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
Cobb WS; Abercrombie ED
Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
[TBL] [Abstract][Full Text] [Related]
31. The xenon-mediated antagonism against the NMDA receptor is non-selective for receptors containing either NR2A or NR2B subunits in the mouse amygdala.
Haseneder R; Kratzer S; Kochs E; Höfelmann D; Auberson Y; Eder M; Rammes G
Eur J Pharmacol; 2009 Oct; 619(1-3):33-7. PubMed ID: 19686722
[TBL] [Abstract][Full Text] [Related]
32. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission.
Ferraro L; Antonelli T; O'Connor WT; Tanganelli S; Rambert FA; Fuxe K
Neurosci Lett; 1998 Sep; 253(2):135-8. PubMed ID: 9774168
[TBL] [Abstract][Full Text] [Related]
33. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission.
Battaglia G; Bruno V; Pisani A; Centonze D; Catania MV; Calabresi P; Nicoletti F
Mol Cell Neurosci; 2001 Jun; 17(6):1071-83. PubMed ID: 11414795
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic GABA neurons inhibit proenkephalin gene expression in slice cultures of rat neostriatum.
Mörl F; Gröschel M; Leemhuis J; Meyer DK
Eur J Neurosci; 2002 Apr; 15(7):1115-24. PubMed ID: 11982623
[TBL] [Abstract][Full Text] [Related]
35. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
36. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
Deng YP; Lei WL; Reiner A
J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290
[TBL] [Abstract][Full Text] [Related]
37. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
38. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
39. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
40. Involvement of NMDA receptor mechanisms in the modulation of serotonin release in the lateral parabrachial nucleus in the rat.
Tanaka J; Miyakubo H; Kawakami A; Hayashi Y; Nomura M
Brain Res Bull; 2006 Dec; 71(1-3):311-5. PubMed ID: 17113961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
